NovaBridge Biosciences - American Depositary Shares (NBP)

I-Mab (NASDAQ:NBP) presented updated Phase 1b data for givastomig, an investigational treatment being developed for frontline metastatic gastric and gastroesophageal cancer, citing longer follow-up that the company said strengthened its confidence in the therapy’s durability, safety profile and pote

The final trading sessions of 2025 have delivered a sobering reality check to a market that spent much of the year in a state of AI-driven euphoria. In a rare departure from the historical "Santa Claus rally," major indices including the S&P 500 and the Nasdaq Composite stumbled through